Title, Institution Award Cycle, Investigator Award [sort]
(-) Lobeline: total synthesis and derivitization 2002 (Cycle XI) $60,000
California Institute of Techno Jeffrey Bagdanoff B.S. 11DT-0193
11th National Conference on Nicotine Dependence 1998 (Cycle VII) $12,000
American Society of Addiction< Lori Karan M.D. 7ST-0198
2nd East West Conference on Tobacco and Alcohol 2005 (Cycle XIV) $15,000
University of Southern Califor Andy Johnson 14ST-0190
2-Xylosides Inhibit Glycolipid Synthesis and Cell Growth 1995 (Cycle IV) $149,221
The Burnham Institute of Medic Hudson Freeze Ph.D. 4IT-0225
50000 Fold Signal Enhancement for Imaging Vulnerable Plaque 2007 (Cycle XVI) $213,845
Huntington Medical Research In Pratip Bhattacharya PhD 16KT-0044
A dynamic model of smoking and healthcare expenditures in CA 2000 (Cycle IX) $595,843
University of California, San< Wendy Max Ph.D. 9RT-0157
A Genetic Marker of Lung Cancer Risk Among Blacks & Whites 1992 (Cycle I) $1,036,615
University of Southern Califor Stephanie London M.D., Ph.D. 1RT-0140
A Hypothalamic Mechanism of Nicotine Reward and Addiction 1993 (Cycle II) $61,640
University of California, San< Dennis Rasmussen Ph.D. 2IT-0040
A longitudinal study of smoking transitions in youth 1999 (Cycle VIII) $577,574
University of California, San< Elizabeth Gilpin M.S. 8RT-0086
A Metabolic Mechanism of Action of Antiischemic Agents 1993 (Cycle II) $225,000
University of California, Los< Freny Mody M.D. 2KT-0049
A Methodological Multi-Ethnic Study of Smoking Initiation 1995 (Cycle IV) $260,978
University of California, Los< Celia Kaplan Dr.P.H. 4RT-0257
A mindfulness-based approach to relapse prevention 2005 (Cycle XIV) $134,325
California Pacific Medical Cen Cassandra Vieten Ph.D. 14IT-0178
A model system for smoking-related damage to proteins 1999 (Cycle VIII) $75,375
J. David Gladstone Institutes< Johan Bjorkegren M.D., Ph.D. 8FT-0022
A New Approach for Studying the Mechanism of Squamous Metapl 1995 (Cycle IV) $75,000
University of California, Los< Sanford Barsky M.D. 4IT-0328
A new molecular approach for predicting lung cancer 2000 (Cycle IX) $75,000
University of California, Irvi Ram Kumar Sindhu Ph.D. 9IT-0121
A novel approach to prevent in utero nicotine lung injury 2005 (Cycle XIV) $553,441
LA Biomedical Research Institu Virender Rehan M.D. 14RT-0073
A novel FMRI smoking craving and reward paradigm 2003 (Cycle XII) $96,949
University of California, Los< John Monterosso Ph.D. 12IT-0198
A novel lung tumor suppressor 1997 (Cycle VI) $144,038
The Burnham Institute of Medic Steven Frisch Ph.D. 6IT-0128
A novel therapeutic target for stroke 1997 (Cycle VI) $71,810
The Burnham Institute of Medic Li-Tao Zhong M.D., Ph.D. 6FT-0157
A novel total synthesis of brazilin and brazilide A 2005 (Cycle XIV) $59,500
University of California, Sant Yaodong Huang M.S. 14DT-0130
A novel, 3-dimensional approach to non-invasive diagnostics 2005 (Cycle XIV) $99,000
University of California, Irvi Petra Wilder-Smith D.D.S., Ph.D. 14IT-0097
A retroviral link to human tobacco-related lung cancer? 1999 (Cycle VIII) $72,500
University of California, Los< Sanford Barsky M.D. 8IT-0046
A Smokeless Tobacco Cessation Intervention:College Athletes 1992 (Cycle I) $648,997
University of California, San< Margaret Walsh MS, EdD 1RT-0574
A Smokeless Tobacco Cessation Program: High School Athletes 1995 (Cycle IV) $533,923
University of California, San< Margaret Walsh MS, EdD 4RT-0068
A Smoking Prevention Model for Low Income Minority Youth 1992 (Cycle I) $323,095
Charles R. Drew University of< Donna Davis Ph.D. 1KT-0035
A stage-based scheduled smoking intervention for Chinese 2005 (Cycle XIV) $554,500
University of California, San< Janice Tsoh Ph.D. 14RT-0160H
A study of Bax, a gene involved in killing tumor cells 1998 (Cycle VII) $74,980
The Burnham Institute of Medic Shahrzad Nouraini Ph.D. 7FT-0100
A web-based support community as a tool for ST cessation 2003 (Cycle XII) $100,000
University of California, San< Margaret Walsh MS, EdD 12IT-0169
Acculturation & cigarette smoking among Asian-Americans 1997 (Cycle VI) $244,715
University of Southern Califor Xinguang Chen Ph.D. 6KT-0191
Acculturation, media, peers, parents and adolescent smoking 1998 (Cycle VII) $132,339
University of Southern Califor Jennifer Unger Ph.D. 7PT-7004H
Acetylcholine Receptors in the Developing Nervous System 1994 (Cycle III) $116,263
University of California, San< Kent Keyser Ph.D. 3RT-0157
Activated Protein C in Smokers Thrombosis 1993 (Cycle II) $347,737
Scripps Research Institute Andras Gruber M.D. 2RT-0342
Activation and detoxification of lung cancer carcinogens 2006 (Cycle XV) $420,000
University of California, San< Robert Tukey Ph.D. 15RT-0251
Activation of Bnip3 in tobacco-induced heart disease 2005 (Cycle XIV) $134,074
Scripps Research Institute Asa Gustafsson Ph.D. 14KT-0109
Activation of Bnip3 in tobacco-induced heart disease 2005 (Cycle XIV) $156,986
San Diego State University Res Asa Gustafsson Ph.D. 14KT-0109A
Activation of NF-kB by cigarette smoke 1999 (Cycle VIII) $224,217
University of California, Davi Richart Harper M.D. 8KT-0092
Acute & Chronic Effects of Tobacco & Non-tobacco Smoking 1992 (Cycle I) $27,491
University of California, Los< Enrique Gil M.D. 1FT-0042
Acute & Chronic Nicotine Treatment on Gastric Ulceration 1992 (Cycle I) $70,000
University of California, Los< Kazuo Endoh M.D. 1FT-0037
Ad and Movie Imagery and Teen's Perceptions About Smokers 1995 (Cycle IV) $183,689
University of California, Irvi Cornelia Pechmann Ph.D. 4RT-0082
Addressing Substance Abusers Who Also Smoke 1994 (Cycle III) $270,931
Northern California Institute< Karen Sees D.O. 3KT-0121
Adenosine Airway Reactivity & Receptors in Smokers 1992 (Cycle I) $93,500
University of California, Davi Jesse Joad M.D. 1RT-0155
Adolescent Susceptibility to Tobacco: A Panel Analysis 1997 (Cycle VI) $465,917
University of California, Irvi Larry Jamner Ph.D. 6PT-3003H
Adolescent susceptibility to tobacco: a panel analysis 2001 (Cycle X) $495,433
University of California, Irvi Larry Jamner Ph.D. 10RT-0255
Advances in Lung Cancer Detection with Digital Techniques 1993 (Cycle II) $276,730
University of California, Los< Denise Aberle M.D. 2RT-0081
Affect Regulation in the Prevention of Smoking Relapse 1993 (Cycle II) $70,601
Northern California Institute< Timothy Carmody Ph.D. 2IT-0014
African American church role in tobacco norm change 2005 (Cycle XIV) $126,317
Health Education Council Ayanna Kiburi M.P.H. 14IT-0188
African Americans and Mentholated Cigarettes 1999 (Cycle VIII) $417,968
Charles R. Drew University of< Bruce Allen Dr. P.H. 8RT-0091H
African Americans: NRT or Alternative Medicine for Cessation 2006 (Cycle XV) $270,000
University of California, San< Valerie Yerger ND, MA 15KT-0038
Aggression and Nicotine 1997 (Cycle VI) $229,826
University of California, Irvi Larry Jamner Ph.D. 6RT-0154
Airway transcriptome changes in smokers 2004 (Cycle XIII) $99,500
University of California, San< John Fahy M.D. 13IT-0097
ALAC 2003 Annual Conference 2003 (Cycle XII) $5,000
American Lung Association of C Steve O'Kane 12ST-0264
ALAC Annual Conference 2005 (Cycle XIV) $2,500
American Lung Association of C Lynn Devine 14ST-0192
ALAC Annual Conference 2006 (Cycle XV) $5,000
American Lung Association of C Kerlyn Chatelain-Graham 15ST-0258
ALAC Annual Conference 2007 (Cycle XVI) $5,000
American Lung Association of C Laura Keegan 16ST-0217
ALAC Conference 2004 (Cycle XIII) $5,000
American Lung Association of C Laura Keegan 13ST-0175
Allocation of Health Care to Smokers: Practice and Ethics 1998 (Cycle VII) $113,598
Stanford University Thomas Raffin M.D. 7IT-0129
Alpha4* Nicotinic Receptor in Dopaminergic System 2007 (Cycle XVI) $75,500
California Institute of Techno Cheng Xiao Ph.D. 16FT-0066
Alterations in gene expression after tobacco smoke exposure 1997 (Cycle VI) $216,612
University of California, Davi Ken Yoneda M.D. 6KT-0016
Alternative sources of ETS exposure in infants 1998 (Cycle VII) $109,687
San Diego State University Res Georg Matt Ph.D. 7IT-0087
Amnesty Smoking Prevention Project 1992 (Cycle I) $686,087
University of Southern Califor Richard Scribner M.D. 1RT-0545
An athletic trainer mediated spit tobacco cessation program 1998 (Cycle VII) $497,539
University of California, San< Margaret Walsh MS, EdD 7RT-0058
An economic analysis of factors influencing teen smoking 1998 (Cycle VII) $221,497
University of California, San< Sherry Emery MBA, Ph.D. 7KT-0193
An Endogenous Lectin in Airway Epithelium & Lung Cancer 1992 (Cycle I) $463,703
University of California, San< Hakon Leffler M.D., Ph.D. 1RT-0279
An Idea for a Cohort Study of Tobacco-Related Cancers 1993 (Cycle II) $73,428
University of California, Los< Matthew Longnecker 2IT-0008
An RNA biomarker for tobacco smoke toxicity 1999 (Cycle VIII) $51,751
University of California, Davi Richard Kimura 8DT-0174
Anabolic therapies for muscle dysfunction in women with COPD 2001 (Cycle X) $632,153
LA Biomedical Research Institu Richard Casaburi M.D., Ph.D. 10RT-0046
Analysis of a candidate lung tumor suppressor gene at 3p21.3 2000 (Cycle IX) $111,410
Beckman Research Institute of< Gerd Pfeifer Ph.D. 9RT-0175
Analysis of a lung tumor supressor gene at 3p21.3 2001 (Cycle X) $249,438
Beckman Research Institute of< Gerd Pfeifer Ph.D. 10RT-0016
Analysis of a nicotine-related receptor binding site 1997 (Cycle VI) $68,718
University of California, San< Laura England Ph.D. 6FT-0103
Analysis of California adolescent tobacco data 2001 (Cycle X) $475,742
University of California, Los< William McCarthy Ph.D. 10RT-0333
Analysis of RAS Mutations in the Canine Smoking Model 1992 (Cycle I) $70,000
University of California, Davi Susan Kraegel D.V.M. 1FT-0073
Analysis of Retinoid Mediated Anti-cancer Activities 1993 (Cycle II) $757,415
The Burnham Institute of Medic Magnus Pfahl Ph.D. 2RT-0109
Analysis of the Effect of Natl Policies on Smoking Behavior 1992 (Cycle I) $579,489
University of California, San< John Pierce Ph.D. 1RT-0245
Analysis of tobacco industry documents on scientific researc 2000 (Cycle IX) $442,646
University of California, San< Lisa Bero Ph.D. 9RT-0193
Angiotensin II and Restenosis after Coronary Angioplasty 1993 (Cycle II) $228,018
University of California, Davi Jerry Powell M.D. 2RT-0326
Angiotensin II Regulation of the Cardiac Fibroblast 1994 (Cycle III) $219,533
University of California, San< Francisco Villarreal M.D., Ph.D. 3KT-0205
Animal Models of Human Risk from Environmental Tobacco Smoke 1994 (Cycle III) $135,482
University of California, Davi Philip Kass D.V.M., Ph.D. 3KT-0071
Antiatherogenic helical segments of apo A-I 2004 (Cycle XIII) $141,230
Lawrence Berkeley National Lab John Bielicki Ph.D. 13IT-0025
Antimicrobial Proteins of Human Alveolar Macrophages 1993 (Cycle II) $71,549
University of California, Los< Robert Lehrer M.D. 2IT-0017
Antioxidants, cigarette smoking and atherosclerosis 1998 (Cycle VII) $730,640
University of Southern Califor James Dwyer Ph.D. 7RT-0034
Antismoking slides in movie Theaters: A Naturalistic Eval 2000 (Cycle IX) $10,000
University of California, Irvi Cornelia Pechmann Ph.D. 9ST-0244
Anti-Tobacco Programming: Reaching Deaf and Hard of Hearing 1997 (Cycle VI) $452,574
University of California, Los< Barbara Berman Ph.D. 6RT-0047
ApoE isoforms, fatty acid metabolism and atherosclerosis 2001 (Cycle X) $691,616
J. David Gladstone Institutes< Robert Pitas Ph.D. 10RT-0313
Apolipoprotein E: remnant metabolism and atherogenesis 1999 (Cycle VIII) $793,474
J. David Gladstone Institutes< Yadong Huang M.D., Ph.D. 8RT-0130
Apolipoprotein(a) and Cardiovascular Disease 1993 (Cycle II) $590,733
Stanford University Richard Lawn Ph.D. 2RT-0339
Ascertainment of environmental tobacco exposure in pregnancy 1999 (Cycle VIII) $1,843,747
Sequoia Foundation Martin Kharrazi Ph.D. 8RT-0115
Asian American and Pacific Islander (AAPI) Sci. Conf./Wkshp. 2007 (Cycle XVI) $5,000
University of California, Los< Yih-Ing Hser Ph.D. 16ST-0214
Assessing nicotine relapse in a mouse model 2001 (Cycle X) $52,817
SRI International Taline Khroyan Ph.D. 10KT-0007
Assessing Organizational Influence on Chinese Smoking 1993 (Cycle II) $75,150
University of California, Los< Virginia Li Ph.D., M.P.H. 2IT-0070
Assessing Tobacco Refusal Skills in Latino Youth 1992 (Cycle I) $584,719
San Diego State University Res James Sallis Ph.D. 1RT-0588
Assessment of Teen Tobacco Use by Primary Care Physicians 1993 (Cycle II) $70,000
University of California, San< Merula Franzgrote M.D. 2FT-0063
Asthma, gender, and ETS: pathogenic synergy 2005 (Cycle XIV) $99,500
University of California, Davi Laurel Gershwin D.V.M., Ph.D. 14IT-0081
Asymmetric Synthesis of (-)-Podophyllotoxin 1993 (Cycle II) $121,946
University of California, Sant Joseph Konopelski Ph.D. 2RT-0004
Autocrine Interactions Between Bombesin and its Receptor 1994 (Cycle III) $316,238
University of California, San< Daniel Donoghue Ph.D. 3RT-0242
BAG-1, a unique gene involved in smoking-associated cancers 1998 (Cycle VII) $75,060
The Burnham Institute of Medic Zhihua Xie Ph.D. 7FT-0092
Bayview-Hunters Point partnership toward smoking cessation 2002 (Cycle XI) $75,000
University of California, San< Ruth Malone Ph.D., RN. 11BT-1701
Bayview-Hunters Point partnership toward smoking cessation 2002 (Cycle XI) $75,000
University of California, San< Carol McGruder B.A. 11BT-1701
Behavioral effects of neonatal nicotine exposure 2000 (Cycle IX) $624,780
San Diego State University Res Edward Riley Ph.D. 9RT-0012
Behavioral epidemiology of tobacco use among gay men 1998 (Cycle VII) $628,233
University of California, San< Greg Greenwood PhD 7RT-0013
Benzo[a]pyrene: Biogenetic Effects on Hepatocytes in Vitro 1995 (Cycle IV) $321,199
University of California, San< Hyam Leffert M.D. 4RT-0076
Benzo[A]pyrene: Biogenetic Effects on Hepatocytes in Vitro 1992 (Cycle I) $482,971
University of California, San< Hyam Leffert M.D. 1RT-0137
Bioactive lipids in tobacco related lung cancers 1997 (Cycle VI) $74,496
University of California, San< Jerold Chun M.D., Ph.D. 6IT-0375
Biochemical and Functional Characterization of HIP-116 1994 (Cycle III) $75,600
Salk Institute for Biological< Philip Sheridan Ph.D. 3FT-0339
Birth defects, smoking and host susceptibility 2003 (Cycle XII) $466,200
March of Dimes Birth Defects F Suzan Carmichael PhD 12RT-0098
Bispecific molecular therapy of small cell lung cancer 2001 (Cycle X) $434,805
University of California, San< Edward Ball M.D. 10RT-0064
Black-White Differences in Menthol Cigarette Smoking 1992 (Cycle I) $332,764
University of California, Los< Murray Jarvik M.D., Ph.D. 1RT-0087
Boosting the immune response against lung cancer 1998 (Cycle VII) $70,000
University of California, Los< Marina Stolina Ph.D. 7FT-0035
Brachial Vasoreactivity in Young Adult Smokers 1997 (Cycle VI) $329,593
Osteoporosis Medical Center Jacques Barth M.D., Ph.D. 6RT-0053
Brain adaptations to chronic nicotine expsoure 1997 (Cycle VI) $402,111
University of California, Irvi Frances Leslie Ph.D. 6RT-0416
Brain imaging in nicotine addiction 2002 (Cycle XI) $419,881
University of California, Los< Desmond Smith Ph.D. 11RT-0172
Brain metabolic changes with cigarette craving 1998 (Cycle VII) $250,850
Brentwood Biomedical Research< Arthur Brody M.D. 7KT-0098
Brain nAChR Occupancy: Effect of Secondhand Smoke 2007 (Cycle XVI) $623,841
Brentwood Biomedical Research< Arthur Brody M.D. 16RT-0098
Brain wave assessment of tobacco cessation readiness 1997 (Cycle VI) $115,486
Scripps Research Institute Aaron Ilan Ph.D. 6KT-0312
Bupropion and nicotine dependence: behavior & neurochemisty 2005 (Cycle XIV) $37,500
Scripps Research Institute Neil Paterson B.Sc., MBCh.B. 14FT-0056
Bupropion for hospital-based smoking cessation 2003 (Cycle XII) $485,200
University of California, San< Joel Simon M.D., M.P.H. 12RT-0148
Bupropion for smoking cessation 1998 (Cycle VII) $471,154
University of California, San< Joel Simon M.D., M.P.H. 7RT-0033
California AB13 compliance and ethnicity in urban bars 2003 (Cycle XII) $769,266
Pacific Institute for Research Roland Moore BA, MA, Ph.D. 12RT-0116
California pharm-assists for smoking cessation 1999 (Cycle VIII) $124,689
SRI International Karen Hudmon Dr.P.H., R.P.H., M.S. 8BT-2301
California pharm-assists for smoking cessation 1999 (Cycle VIII) $124,689
SRI International Marilyn Shreve R.Ph. 8BT-2301
Calorigenic and Atherogenic Effects of Smoking and Nicotine 1995 (Cycle IV) $357,492
University of California, San< Marc Hellerstein M.D., Ph.D. 4RT-0233
Cambodian research initiative 2003 (Cycle XII) $106,456
California State University, L Robert Friis Ph.D. 12BT-2201
Cambodian research initiative 2003 (Cycle XII) $106,456
California State University, L Him Chhim MS, MPA 12BT-2201
Can Computer Games Prevent Tobacco Use? 1994 (Cycle III) $105,362
Stanford University C. Barr Taylor M.D. 3IT-0114
Carbon monoxide and the brain growth spurt 1998 (Cycle VII) $464,268
University of California, Los< John Edmond Ph.D. 7RT-0039
Carbon monoxide as a modulator of myocardial function 1999 (Cycle VIII) $225,000
University of California, Davi Ulrike Kreutzer Ph.D. 8KT-0042
Cardiac Arrythmias Before and After Smoking Cessation 1995 (Cycle IV) $93,780
University of California, San< Melvin Scheinman M.D. 4RT-0069
Cardiac ion channels and tobacco-related disease 2002 (Cycle XI) $389,983
University of California, Sant Carol Vandenberg Ph.D. 11RT-0114
Cardiovascular responses through spinal nicotinic receptors 2001 (Cycle X) $448,941
University of California, San< Palmer Taylor Ph.D. 10RT-0107
Cardiovascular responses to nicotine 1997 (Cycle VI) $430,843
University of California, San< Palmer Taylor Ph.D. 6RT-0009
Carotid Body Amplification of Exertional Dyspnea in Smokers 1992 (Cycle I) $196,560
University of California, Los< Susan Ward Ph.D. 1RT-0272
Case studies of indoor air regulations: role of research 1997 (Cycle VI) $292,210
University of California, San< Lisa Bero Ph.D. 6RT-0025
Case study on tobacco use legislation 1992 (Cycle I) $160,907
RAND Corporation Peter Jacobson J.D., M.P.H. 1RT-0529
Cell adhesion at nicotinic synapses 2005 (Cycle XIV) $59,500
University of California, San< Gallen Triana-Balzer B.A. 14DT-0092
Cell Adhesion Receptors in Atherogenesis 1994 (Cycle III) $170,341
The Burnham Institute of Medic Jeffrey Smith Ph.D. 3RT-0258A
Cell Adhesion Receptors in Atherogenesis 1994 (Cycle III) $391,252
Scripps Research Institute Jeffrey Smith Ph.D. 3RT-0258